Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

Burkina Faso

Novartis Investigative Site, Banfora

Novartis Investigative Site, Nanoro

Côte d’Ivoire

Novartis Investigative Site, Abidjan

Novartis Investigative Site, Azaguié

Gabon

Novartis Investigative Site, Lambaréné

Novartis Investigative Site, Libreville

Ghana

Novartis Investigative Site, Kintampo

Novartis Investigative Site, Navrango

Kenya

Novartis Investigative Site, Ahero, Kisumu County

Novartis Investigative Site, Kisumu

Uganda

Novartis Investigative Site, Kampala

Novartis Investigative Site, Tororo